The Administrative Component oversees the DRTC's missions of excellence in interdisciplinary research, thetraining and development of new diabetes investigators, and enrichment of the diabetes researchenvironment at Vanderbilt and nationally. The DRTC leadership consists of: Director (Alvin Powers); twoAssociate Directors (Alan Cherrington and Stephen Davis); and an Executive Committee (Naji Abumrad,Matthew Breyer, Thomas Elasy, David Piston, Roland Stein, David Wasserman, Christopher Wright). Allmembers of the DRTC leadership have made important contributions to diabetes-related research and bringconsiderable research and administrative expertise and perspective. This senior leadership also has a longhistory of productive collaborations and interactions among themselves and with other centers at Vanderbilt.The DRTC leadership is responsible for determining the membership of the DRTC, allocating DRTC supportof research cores, overseeing the Pilot and Feasibility Program and DRTC training efforts, and developinglong-term DRTC strategy (requests for institutional support, recruiting, relationships with other centers).Vanderbilt University Medical Center (VUMC) continues to make a sustained and substantial commitment ofspace and resources to the DRTC, and the Administrative Component is responsible for integrating this withsupport provided by the NIH. The Administrative Component also is responsible for the planning andorganization of research symposia, lectureship schedules, and the annual Diabetes Center Research Day.In these efforts, the Director and the Administrative Component of the DRTC receive advice from: 1) anInternal Advisory Committee, appointed by the Dean, that provides advice, especially regarding therelationship of the DRTC to other parts of VUMC; 2) an External Advisory Committee; 3) the Pilot andFeasibility Review Committee; 4) Research Advisory Committee that consists of co-leaders from the sevenDRTC research areas; and 5) a Research Training Advisory Committee that overseeing DRTC-affiliatedtraining grants and efforts. The Administrative Component also includes considerable informatics expertiseto create and utilize a variety of electronic approaches to effectively communicate with DRTC members andthe diabetes research community outside Vanderbilt and to provide informatics support to DRTC-affiliatedmembers. In summary, an experienced and effective DRTC management team, bolstered by sustained andsubstantial support from VUMC, is working to ensure that the Vanderbilt DRTC's research base, corefacilities, training activities, and enrichment efforts continue to be outstanding and at the forefront of diabetesresearch. In addition, the DRTC leadership is interested in working collaboratively with other diabetescenters, the NIDDK, and other interested organizations to enhance and facilitate diabetes researchthroughout the United States.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Comprehensive Center (P60)
Project #
2P60DK020593-29
Application #
7284639
Study Section
Special Emphasis Panel (ZDK1-GRB-N (J1))
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
29
Fiscal Year
2007
Total Cost
$587,703
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Creecy, Amy; Uppuganti, Sasidhar; Unal, Mustafa et al. (2018) Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age. Bone 110:204-214
Russart, Kathryn L G; Huk, Danielle; Nelson, Randy J et al. (2018) Elevated aggressive behavior in male mice with thyroid-specific Prkar1a and global Epac1 gene deletion. Horm Behav 98:121-129
Coppola, Jennifer J; Disney, Anita A (2018) Most calbindin-immunoreactive neurons, but few calretinin-immunoreactive neurons, express the m1 acetylcholine receptor in the middle temporal visual area of the macaque monkey. Brain Behav 8:e01071
Zhu, Lin; Luu, Thao; Emfinger, Christopher H et al. (2018) CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet. Diabetes 67:2494-2506
Lu, Sichang; McGough, Madison A P; Shiels, Stefanie M et al. (2018) Settable polymer/ceramic composite bone grafts stabilize weight-bearing tibial plateau slot defects and integrate with host bone in an ovine model. Biomaterials 179:29-45
Horwitz, Elad; Krogvold, Lars; Zhitomirsky, Sophia et al. (2018) ?-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes. Diabetes 67:2305-2318
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Hull, P C; Buchowski, M; Canedo, J R et al. (2018) Childhood obesity prevention cluster randomized trial for Hispanic families: outcomes of the healthy families study. Pediatr Obes 13:686-696
Harris, Nicholas A; Isaac, Austin T; Günther, Anne et al. (2018) Dorsal BNST ?2A-Adrenergic Receptors Produce HCN-Dependent Excitatory Actions That Initiate Anxiogenic Behaviors. J Neurosci 38:8922-8942
Wang, Feng; Katagiri, Daisuke; Li, Ke et al. (2018) Assessment of renal fibrosis in murine diabetic nephropathy using quantitative magnetization transfer MRI. Magn Reson Med 80:2655-2669

Showing the most recent 10 out of 1487 publications